BrightInsight is a finalist in the 2022 Fierce Life Sciences Innovation Awards

Fierce awards 2022

For the second year in a row, BrightInsight is a finalist in the annual Fierce Life Sciences Awards, in the Digital Health Solutions category. According to the publishers of Fierce Biotech and Fierce Pharma, the Fierce Innovation Awards: Life Sciences Edition identify and showcase outstanding innovation that is driving improvements and transforming the industry.

An expert panel of judges reviewed submissions and selected companies that demonstrate innovative technologies and services that have the potential to make the greatest impact for biotech and pharma companies.

BrightInsight has definitely had an outsized impact in 2022, helping many of the top global biopharma, medtech and diagnostics companies—including six of the top 10 biopharma companies—build and launch digital solutions to improve patient care, reduce costs, improve disease management, cut costs—and most importantly, drive innovation. Our company achieved several significant milestones this year including:

We are honored to be a finalist for this highly regarded annual award. This recognition is a validation of the need and adoption of our regulated digital solutions enabling biopharma and medtech to improve health care. Be sure to check out Fierce’s Innovation Report featuring all the finalists and announcing the winners, coming out November 14.

Back to Blog